WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+3.65%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$2.91B
AUM Growth
+$763M
(+36%)
Cap. Flow
+$664M
Cap. Flow
% of AUM
22.83%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
645
New
149
Increased
138
Reduced
132
Closed
154
Top Buys
| 1 |
American Homes 4 Rent
AMH
|
$66.5M |
| 2 |
Equity Lifestyle Properties
ELS
|
$46.8M |
| 3 |
STAG Industrial
STAG
|
$46.3M |
| 4 |
DCT
DCT Industrial Trust Inc.
DCT
|
$44M |
| 5 |
Boston Properties
BXP
|
$38.3M |
Top Sells
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
$33.4M |
| 2 |
Canadian National Railway
CNI
|
$31.7M |
| 3 |
Ventas
VTR
|
$25.9M |
| 4 |
Agree Realty
ADC
|
$18M |
| 5 |
Ryder
R
|
$17.9M |
Sector Composition
| 1 | Real Estate | 24.7% |
| 2 | Industrials | 10.77% |
| 3 | Consumer Discretionary | 10.15% |
| 4 | Technology | 9.79% |
| 5 | Consumer Staples | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STAY
401
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $346K | 0.01% |
15,988
-159,012
| -91% | -$3.44M |
|
402
Karyopharm Therapeutics
KPTI
$57.2M
| $340K | 0.01% |
+1,333
| New | +$340K |
|
403
Aldeyra Therapeutics
ALDX
$334M
| $320K | 0.01% |
40,200
-7,200
| -15% | -$57.3K |
|
|
INSY
404
DELISTED
Insys Therapeutics, Inc.
INSY
| $317K | 0.01% |
43,830
+7,130
| +19% | +$51.6K |
|
|
BPMC
405
DELISTED
Blueprint Medicines
BPMC
| $317K | 0.01% |
+5,000
| New | +$317K |
|
|
BHVN
406
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $316K | 0.01% |
+8,000
| New | +$316K |
|
|
OBSV
407
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $303K | 0.01% |
20,000
| – | – |
|
408
Electronic Arts
EA
$42.2B
| $282K | 0.01% |
+2,000
| New | +$282K |
|
|
KERX
409
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $255K | 0.01% |
67,929
+5,929
| +10% | +$22.3K |
|
|
AXDX
410
DELISTED
Accelerate Diagnostics
AXDX
| $245K | 0.01% |
+1,100
| New | +$245K |
|
411
InflaRx
IFRX
$112M
| $245K | 0.01% |
7,600
+600
| +9% | +$19.3K |
|
412
United Airlines
UAL
$34.5B
| $230K | 0.01% |
3,300
-5,628
| -63% | -$392K |
|
413
CytomX Therapeutics
CTMX
$376M
| $229K | 0.01% |
+10,000
| New | +$229K |
|
|
BKS
414
DELISTED
Barnes & Noble
BKS
| $222K | 0.01% |
35,000
-65,000
| -65% | -$412K |
|
415
Q32 Bio
QTTB
$20.4M
| $204K | ﹤0.01% |
556
-1,666
| -75% | -$611K |
|
416
Owens & Minor
OMI
$434M
| $184K | ﹤0.01% |
10,993
+993
| +10% | +$16.6K |
|
417
Ramaco Resources Class A
METC
$1.86B
| $176K | ﹤0.01% |
26,177
-103,022
| -80% | -$693K |
|
418
Pacific Biosciences
PACB
$381M
| $175K | ﹤0.01% |
49,326
+4,326
| +10% | +$15.3K |
|
419
Cytokinetics
CYTK
$6.34B
| $166K | ﹤0.01% |
20,000
-15,000
| -43% | -$125K |
|
420
Akebia Therapeutics
AKBA
$785M
| $142K | ﹤0.01% |
14,234
+1,234
| +9% | +$12.3K |
|
|
IMDZ
421
DELISTED
Immune Design Corp.
IMDZ
| $125K | ﹤0.01% |
27,500
-52,500
| -66% | -$239K |
|
422
Arcus Biosciences
RCUS
$1.3B
| $122K | ﹤0.01% |
+10,000
| New | +$122K |
|
|
ELGX
423
DELISTED
Endologix Inc
ELGX
| $120K | ﹤0.01% |
2,114
+184
| +10% | +$10.4K |
|
|
CMBT
424
CMB.TECH NV
CMBT
$2.64B
| $103K | ﹤0.01% |
+11,225
| New | +$103K |
|
|
ANW
425
DELISTED
Aegean Marine Petroleum Network
ANW
| $101K | ﹤0.01% |
152,675
+63,267
| +71% | +$41.9K |
|